Prothena Corporation plc
PRTA
$8.86
-$0.22-2.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -77.15% | 1,706.36% | -99.01% | 148.97% | -96.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -77.15% | 1,706.36% | -99.01% | 148.97% | -96.65% |
| Cost of Revenue | -78.29% | -75.15% | -70.93% | -42.95% | -29.55% |
| Gross Profit | 78.42% | 180.15% | 69.69% | 46.69% | -148.45% |
| SG&A Expenses | -31.50% | -28.03% | -24.94% | -21.01% | -1.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -65.09% | -63.03% | -59.37% | -37.50% | -23.37% |
| Operating Income | 64.07% | 139.33% | 58.07% | 40.22% | -189.09% |
| Income Before Tax | 77.05% | 153.32% | 63.73% | 38.31% | -224.86% |
| Income Tax Expenses | -100.00% | 100.08% | 100.65% | 55.57% | 2,297.25% |
| Earnings from Continuing Operations | 85.22% | 154.36% | 62.75% | 38.07% | -288.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.22% | 154.36% | 62.75% | 38.07% | -288.03% |
| EBIT | 64.07% | 139.33% | 58.07% | 40.22% | -189.09% |
| EBITDA | 64.29% | 139.74% | 58.26% | 40.36% | -188.35% |
| EPS Basic | 84.75% | 154.48% | 62.75% | 38.12% | -287.82% |
| Normalized Basic EPS | 65.49% | 146.51% | 58.68% | 39.16% | -174.49% |
| EPS Diluted | 84.62% | 153.57% | 62.75% | 38.12% | -291.80% |
| Normalized Diluted EPS | 65.49% | 146.15% | 58.68% | 39.16% | -176.26% |
| Average Basic Shares Outstanding | -3.12% | -0.22% | 0.03% | 0.07% | 0.11% |
| Average Diluted Shares Outstanding | -3.12% | 0.52% | 0.03% | 0.07% | -2.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |